Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Metastases to liver
ADR ID BADD_A02759
ADR Hierarchy
09      Hepatobiliary disorders
09.04      Hepatobiliary neoplasms
09.04.02      Malignant hepatobiliary neoplasms
09.04.02.004      Metastases to liver
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.22      Metastases
16.22.02      Metastases to specified sites
16.22.02.001      Metastases to liver
Description Not Available
MedDRA Code 10027457
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Cancer of liver, secondary | Hepatic metastases | Liver metastases | Malignant neoplasm of liver, specified as secondary | Metastases to liver
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02154Tenofovir0.002908%
BADD_D02257Trametinib0.000414%
BADD_D02331Valsartan0.000185%
BADD_D02334Vandetanib0.000280%
BADD_D02344Vemurafenib0.000280%
BADD_D02369Voriconazole0.014521%
BADD_D02392Zoledronic acid--
BADD_D02407Upadacitinib0.000651%
BADD_D02412Octreotide0.002422%
BADD_D02464Fingolimod0.002291%
BADD_D02469Edoxaban0.000082%
BADD_D02480Alectinib0.000224%
BADD_D02483Ribociclib0.001959%
BADD_D02490Apalutamide0.000334%
BADD_D02498Abemaciclib0.000381%
BADD_D02500Alpelisib0.000392%
BADD_D02503Telotristat ethyl-
BADD_D02509Brigatinib0.000616%
BADD_D02510Rucaparib0.000224%
BADD_D02526Larotrectinib0.000168%
BADD_D02553Entrectinib0.000112%
BADD_D02568Lutetium oxodotreotide lu-177-
BADD_D02586Radium ra-223 dichloride-
BADD_D02591Ripretinib0.000336%
BADD_D02603Tucatinib0.000168%
The 3th Page    First    Pre   3    Total 3 Pages